Mansilla-Polo, M, Benvant, MP, Fernández-Crehuet, P, Vilarrasa, E, Albanell-Fernández, C, Morales-Tedone, E, Rausell-Félix, F, Alcalá-García, R, Matellanes-Palacios, M, Martín-Ezquerra, G, Alfageme, F, Blanco, CC, López-Villaescusa, MT, Salmons, PG, Martorell, A, Muñoz, BE, Navarro-Blanco, F, Torregrosa, DM, Barrales, CC, Leyva, AM, Botella-Estrada, R. Bimekizumab demonstrates effective responses and safety in hidradenitis suppurativa: Short-term real-world observational multicentric study from Spain. EXPERIMENTAL DERMATOLOGY. 2025; 34DOI:. PMID:. IF:3.100(Q2/3D).

Giavedoni, P, Romaní, J, de Cabo, F, García-Martínez, FJ, Quintana-Codina, M, Roè-Crespo, E, de Vega, IF, Soria-Gili, X, Aguayo-Ortiz, R, Garbayo-Salmons, P, Castillo, G, Vidal-Sarró, D, Mollet, J, Serra, L, Gonzalez, C, López-Trujillo, E, Just, M, Combalia, M, Podlipnik, S, Malvehy, J, Wortsman, X. Advanced Doppler Ultrasound Insights: A Multicenter Prospective Study on Healthy Skin. Diagnostics. 2025; 15(5)DOI:10.3390/diagnostics15050569. PMID:40075816. IF:3.300(Q1/2D).

Barker, JN, Casanova, E, Choon, SE, Foley, P, Fujita, H, Gonzalez, C, Gooderham, M, Marrakchi, S, Puig, L, Romiti, R, Thaçi, D, Zheng, M, Strober, B. Global Delphi consensus on treatment goals for generalized pustular psoriasis. BRITISH JOURNAL OF DERMATOLOGY. 2025; 192(4)DOI:10.1093/bjd/ljae491. PMID:39844356. IF:9.600(Q1/1D).

Puig, L. Postswitching discontinuation of biosimilars in psoriasis: registry analyses fall short in addressing real-world biases. BRITISH JOURNAL OF DERMATOLOGY. 2025; 192(4)DOI:10.1093/bjd/ljaf003. PMID:39761694. IF:9.600(Q1/1D).